Patent applications and USPTO patent grants for Scannon; Patrick J..The latest application filed is for "cardiovascular related uses of il-1beta antibodies and binding fragments thereof".
Patent | Date |
---|---|
Cardiovascular Related Uses Of Il-1beta Antibodies And Binding Fragments Thereof App 20210009679 - Scannon; Patrick J. ;   et al. | 2021-01-14 |
Cardiovascular related uses of IL-1.beta. antibodies and binding fragments thereof Grant 10,611,832 - Scannon , et al. | 2020-04-07 |
Flexible manufacturing system Grant 10,294,658 - Scannon , et al. | 2019-05-21 |
Flexible manufacturing system Grant 10,106,974 - Scannon , et al. October 23, 2 | 2018-10-23 |
Cardiovascular Related Uses Of Il-1beta Antibodies And Binding Fragments Thereof App 20180155420 - Scannon; Patrick J. ;   et al. | 2018-06-07 |
Flexible Manufacturing System App 20170058508 - Scannon; Patrick J. ;   et al. | 2017-03-02 |
Methods for the treatment of IL-1.beta. related diseases Grant 9,163,082 - Solinger , et al. October 20, 2 | 2015-10-20 |
Methods For The Treatment Of Il-1beta Related Diseases App 20140255391 - Solinger; Alan M. ;   et al. | 2014-09-11 |
Methods For Improvement Of Beta Cell Function App 20140017249 - Scannon; Patrick J. ;   et al. | 2014-01-16 |
Methods for the treatment of IL-1.beta. related diseases Grant 8,586,036 - Solinger , et al. November 19, 2 | 2013-11-19 |
Flexible manufacturing system Grant 8,584,349 - Scannon , et al. November 19, 2 | 2013-11-19 |
Methods for treating IL-1.beta. related diseases by administering an anti-IL-1.beta. antibody Grant 8,545,846 - Scannon , et al. October 1, 2 | 2013-10-01 |
Flexible Manufacturing System App 20130067721 - Scannon; Patrick J. ;   et al. | 2013-03-21 |
Methods for improvement of beta cell function with anti-IL-1.beta. antibodies or fragments thereof Grant 8,377,429 - Scannon , et al. February 19, 2 | 2013-02-19 |
Methods for the treatment of IL-1.beta. related diseases Grant 8,101,166 - Solinger , et al. January 24, 2 | 2012-01-24 |
Methods For Treating Or Preventing Il-1beta Related Diseases App 20120003226 - Scannon; Patrick J. ;   et al. | 2012-01-05 |
Methods For Improvement Of Beta Cell Function App 20120005127 - Scannon; Patrick J. ;   et al. | 2012-01-05 |
Flexible Manufacturing System App 20110258837 - Scannon; Patrick J. ;   et al. | 2011-10-27 |
Methods For The Treatment Of Il-1beta Related Diseases App 20110038859 - Solinger; Alan M. ;   et al. | 2011-02-17 |
Cardiovascular Related Uses Of Il-1beta Antibodies And Binding Fragments Thereof App 20100316651 - SCANNON; PATRICK J. ;   et al. | 2010-12-16 |
Methods For The Treatment Of Il-1beta Related Diseases App 20100303807 - Solinger; Alan M. ;   et al. | 2010-12-02 |
Methods for the treatment of IL-1.beta. related diseases Grant 7,695,718 - Solinger , et al. April 13, 2 | 2010-04-13 |
Methods For The Treatment Of Il-1beta Related Diseases App 20080292640 - Solinger; Alan M. ;   et al. | 2008-11-27 |
Method of treating chronic cardiac disease App 20060171937 - Giroir; Brett P. ;   et al. | 2006-08-03 |
Method of treating chronic cardiac disease Grant 7,045,501 - Giroir , et al. May 16, 2 | 2006-05-16 |
Method of treating chronic cardiac disease App 20030216312 - Giroir, Brett P. ;   et al. | 2003-11-20 |
Therapeutic uses of BPI protein products in cystic fibrosis patients App 20030194377 - Carroll, Stephen Fitzhugh ;   et al. | 2003-10-16 |
Therapeutic uses of BPI protein products for human meningococcemia Grant 6,596,691 - Giroir , et al. July 22, 2 | 2003-07-22 |
Methods of treating conditions associated with corneal injury App 20030017986 - Scannon, Patrick J. | 2003-01-23 |
Methods of treating conditions associated with corneal injury App 20020128191 - Scannon, Patrick J. | 2002-09-12 |
Therapeutic uses of BPI protein products for human meningococcemia App 20020103114 - Giroir, Brett P. ;   et al. | 2002-08-01 |
Human therapeutic uses of BPI Protein products App 20020094952 - Friedmann, Nadav ;   et al. | 2002-07-18 |
Potentiation of cytotoxic conjugates Grant 4,925,922 - Byers , et al. May 15, 1 | 1990-05-15 |
Ribosomal inhibiting protein-immunoglobulin conjugates with specificity for tumor cell surface antigens, and mixtures thereof Grant 4,916,213 - Scannon , et al. April 10, 1 | 1990-04-10 |
Human melanoma specific immunotoxins Grant 4,590,071 - Scannon , et al. May 20, 1 | 1986-05-20 |
Intramolecularly crosslinked hemoglobin Grant 4,473,496 - Scannon September 25, 1 | 1984-09-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.